SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-142366
Filing Date
2019-05-09
Accepted
2019-05-09 09:04:25
Documents
32
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d709188d10q.htm 10-Q 215490
2 EX-31.1 d709188dex311.htm EX-31.1 6326
3 EX-31.2 d709188dex312.htm EX-31.2 6329
4 EX-32.1 d709188dex321.htm EX-32.1 2925
5 EX-32.2 d709188dex322.htm EX-32.2 2932
  Complete submission text file 0001193125-19-142366.txt   1390749

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20190331.xml EX-101.INS 180608
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20190331.xsd EX-101.SCH 18145
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20190331_cal.xml EX-101.CAL 15422
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20190331_def.xml EX-101.DEF 95708
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20190331_lab.xml EX-101.LAB 157612
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20190331_pre.xml EX-101.PRE 125317
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 19809006
SIC: 8731 Services-Commercial Physical & Biological Research